1-6 of 6
Sukjoong Oh, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim
Journal: Blood
Blood (2019) 134 (Supplement_1): 1643.
https://doi.org/10.1182/blood-2019-126376
Published: 2019
Journal Articles

Long-Term Follow-up after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia: The Korean Imatinib Discontinuation (KID) Study

Dae Young Zang, MD PhD, Won Sik Lee, MD PhD, Yeung-Chul Mun, Young Rok Do, PhD MD, Sukjoong Oh, MD PhD, Sung-Eun Lee, MD PhD, Soo Young Choi, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4252.
https://doi.org/10.1182/blood-2018-99-118026
Published: 2018
Journal Articles

Prognostic Implication of Early Molecular Response at 3 Months in Chronic Myeloid Leukemia Patients: A Comparison of Imatinib and Second Generation Tyrosine Kinase Inhibitors

Dong-Wook Kim, MD PhD, Sung-Eun Lee, MD PhD, Soo Young Choi, Dae Young Zang, MD PhD, Won-Sik Lee, Yeung-Chul Mun, Young Rok Do, PhD MD, Sukjoong Oh, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3017.
https://doi.org/10.1182/blood-2018-99-117631
Published: 2018
Journal Articles

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Jieun Uhm, MD PhD, Sung-Hyun Kim, MD PhD, Sukjoong Oh, MD PhD, Dae Young Zang, MD PhD, Young Rok Do, PhD MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Sung-Eun Lee, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3010.
https://doi.org/10.1182/blood-2018-99-117543
Published: 2018
Journal Articles

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

Yunjeong OH, Soo Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD PhD, Joon Seong Park, MD, Seong Hyun Jeong, MD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD, Sukjoong Oh, MD PhD, Dong Hoe Koo, MD, Hawk Kim, Young Rok Do, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Yeung-Chul Mun, Won Sik Lee, MD PhD, Myung Hee Jang, MD, Jinny Park, MD PhD, Ho-Jin Shin, MD, PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3155.
https://doi.org/10.1182/blood.V124.21.3155.3155
Published: 2014
Journal Articles

Achieving Complete Cytogenetic Response and BCR-ABL PCR IS <1% within 12 Moths Are Important Goals for Imatinib Therapy in Newly Diagnosed, TKI-Naive Chronic Myeloid Leukemia Accelated Phase Patients

Hawk Kim, Eun-Jung Jang, Sung-Eun Lee, Won Sik Lee, MD PhD, Sukjoong Oh, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3158.
https://doi.org/10.1182/blood.V124.21.3158.3158
Published: 2014